Sign In
Buy AUTL
$1.62
-0.130 (-7.43%)
At Close: Jun 03, 2026
Autolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic Leukemia
11:00am, Thursday, 16'th Apr 2020
Autolus Therapeutics plc (AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, announces that the U.S. Food and Drug
Ladenburg Thalmann Financial Services Inc. Takes Position in Autolus Therapeutics Ltd - (NASDAQ:AUTL)
10:50am, Wednesday, 15'th Apr 2020
Ladenburg Thalmann Financial Services Inc. acquired a new position in Autolus Therapeutics Ltd – (NASDAQ:AUTL) in the fourth quarter, according to the company in its most recent Form 13F filing with
Head to Head Review: Autolus Therapeutics (NASDAQ:AUTL) and LogicBio Therapeutics (NASDAQ:LOGC)
06:28am, Monday, 06'th Apr 2020
Autolus Therapeutics (NASDAQ:AUTL) and LogicBio Therapeutics (NASDAQ:LOGC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the s
Autolus Therapeutics (NASDAQ:AUTL) Rating Lowered to Hold at Zacks Investment Research
08:50am, Sunday, 05'th Apr 2020
Zacks Investment Research downgraded shares of Autolus Therapeutics (NASDAQ:AUTL) from a buy rating to a hold rating in a research note published on Wednesday, Zacks.com reports. According to Zacks, �
Stocks To Watch: OPEC Goes Virtual
01:04pm, Saturday, 04'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Autolus Therapeutics Ltd - (NASDAQ:AUTL) Given Consensus Recommendation of "Buy" by Brokerages
07:38am, Saturday, 04'th Apr 2020
Shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) have been given an average rating of “Buy” by the six research firms that are covering the stock, Marketbeat reports. One research analyst has
Capital World Investors Increases Holdings in Autolus Therapeutics Ltd - (NASDAQ:AUTL)
12:18pm, Sunday, 29'th Mar 2020
Capital World Investors grew its holdings in shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 29.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange C
Alyeska Investment Group L.P. Purchases 33,344 Shares of Autolus Therapeutics Ltd - (NASDAQ:AUTL)
08:22am, Saturday, 21'st Mar 2020
Alyeska Investment Group L.P. increased its position in Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 19.2% during the fourth quarter, according to the company in its most recent 13F filing with the S
Arix Bioscience Fiscal 2019 – moving with the times - DirectorsTalk
10:16am, Thursday, 19'th Mar 2020
Arix Bioscience (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-s
Fmr LLC Trims Holdings in Autolus Therapeutics Ltd - (NASDAQ:AUTL)
12:56pm, Saturday, 14'th Mar 2020
Fmr LLC decreased its position in shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 31.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commi
Head-To-Head Survey: Autolus Therapeutics (NASDAQ:AUTL) & Iovance Biotherapeutics (NASDAQ:IOVA)
06:34am, Friday, 13'th Mar 2020
Autolus Therapeutics (NASDAQ:AUTL) and Iovance Biotherapeutics (NASDAQ:IOVA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * Enz
Autolus Therapeutics Ltd - (NASDAQ:AUTL) Given Consensus Rating of "Buy" by Brokerages
09:48am, Tuesday, 10'th Mar 2020
Shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) have been given an average rating of “Buy” by the six analysts that are currently covering the company, MarketBeat Ratings reports. One investm
